C12Y 601/01016
Cysteine-trna ligase
Official title: Cysteine-tRNA ligase (6.1.1.16)
C12Y601/01016 (Cysteine-trna ligase) appears on 9 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 10
- Assignees
- 10
- Inventors
- 16
- Latest grant
- 9 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cysteine polysulfidation and mitochondrial bioenergetics regulated by cysteinyl-tRNA synthetase9 Jan 2024US 11,866,752 B2Bio-Xcelerator, Inc.
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Cysteinyl-tRNA synthetase21 Jul 2020US 10,717,786 B2aTye Pharma, Inc.
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase24 Jul 2018US 10,030,077 B2aTyr Pharma, Inc.
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Cysteinyl-tRNA synthetase10 Jan 2017US 9,540,629 B2aTyr Pharma, Inc.
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase17 Mar 2015US 8,980,253 B2aTyr Pharma, Inc.
- Novel crs fragment peptide with immunopotentiating activity, and use thereof12 Feb 2026US 2026/0041745 A1Zymedi Co., Ltd.
- Cysteine polysulfidation and mitochondrial bioenergetics regulated by cysteinyl-trna synthetase17 Jul 2025US 2025/0230476 A1Bio-Xcelerator, Inc.
- Novel fragmented crs peptide exhibiting immune enhancement activity, and use thereof3 Apr 2025US 2025/0108102 A1Zymedi Co., Ltd.
- Cysteine polysulfidation and mitochondrial bioenergetics regulated by cysteinyl-trna synthetase14 Mar 2024US 2024/0084342 A1Bio-Xcelerator, Inc.
- Cysteine polysulfidation and mitochondrial bioenergetics regulated by cysteinyl-trna synthetase30 Dec 2021US 2021/0403963 A1Bio-Xcelerator, Inc.
Most cited
By later US patents
- DNA encoding cysteinyl tRNA synthetase from Staphylococcus aureus67US 5,776,749 ASmithKline Beecham Corporation · 1998
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase9US 8,980,253 B2aTyr Pharma, Inc. · 2015
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Cysteinyl-tRNA synthetase4US 9,540,629 B2aTyr Pharma, Inc. · 2017
- Methods and composition for inhibition of tRNA activities2US 6,448,059 B1Thomas Jefferson University · 2002